Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
5.41
-0.18 (-3.22%)
At close: May 22, 2026, 4:00 PM EDT
5.45
+0.04 (0.74%)
After-hours: May 22, 2026, 7:59 PM EDT
Aspire Biopharma Holdings Revenue
Aspire Biopharma Holdings had revenue of $28.35K in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $34.56K. In the year 2025, Aspire Biopharma Holdings had annual revenue of $6.20K.
Revenue (ttm)
$34.56K
Revenue Growth
n/a
P/S Ratio
26.22
Revenue / Employee
n/a
Employees
n/a
Market Cap
906.01K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.20K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionASBP News
- 16 days ago - Aspire Biopharma Holdings Inc trading halted, news pending - TheFly
- 18 days ago - Aspire Biopharma to effect 1-for-30 reverse stock split - TheFly
- 18 days ago - Aspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split Ratio - Accesswire
- 4 weeks ago - Aspire Biopharma announces $5M share repurchase plan - TheFly
- 4 weeks ago - Aspire Biopharma Announces $5.0 Million Share Repurchase Program - Accesswire
- 5 weeks ago - Aspire Biopharma closes final tranche of $21M private placement - TheFly
- 5 weeks ago - Aspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS Acquisition - Accesswire
- 5 weeks ago - Buzz Bomb brand ambassador to attempt fastest 100-mile treadmill run - TheFly